SERA PROGNOSTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
SERA PROGNOSTICS, INC. (SERA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price of $3.90 per share as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice · last filed 2026-08-12
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $3.90.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $3.93.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $3.95.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $3.94.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2026-06-30 | $3.90 10-Q · filed 2026-08-12 |
| 2026-03-31 | $3.93 10-Q · filed 2026-05-06 |
| 2025-12-31 | $3.95 10-K · filed 2026-03-18 |
| 2025-09-30 | $3.94 10-Q · filed 2025-11-13 |
| 2025-06-30 | $3.90 10-Q · filed 2025-08-06 |
| 2025-03-31 | $3.87 10-Q · filed 2025-05-07 |
| 2024-12-31 | $3.77 10-K · filed 2025-03-19 |
| 2024-09-30 | $3.63 10-Q · filed 2024-11-06 |
| 2024-06-30 | $3.54 10-Q · filed 2024-08-07 |
| 2024-03-31 | $3.39 10-Q · filed 2024-05-08 |
| 2023-12-31 | $3.28 10-K · filed 2024-03-20 |
| 2023-09-30 | $3.15 10-Q · filed 2023-11-08 |
| 2023-06-30 | $3.09 10-Q · filed 2023-08-09 |
| 2023-03-31 | $3.02 10-Q · filed 2023-05-10 |
| 2022-12-31 | $3.12 10-K · filed 2023-03-22 |
| 2022-09-30 | $2.95 10-Q · filed 2022-11-09 |
| 2022-06-30 | $2.85 10-Q · filed 2022-08-10 |
| 2022-03-31 | $2.51 10-Q · filed 2022-05-10 |
| 2021-12-31 | $2.17 10-K · filed 2022-03-29 |
| 2021-09-30 | $1.98 10-Q · filed 2021-11-09 |
| 2021-06-30 | $1.83 10-Q · filed 2021-08-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |